Plus Therapeutics
Phase 1Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor
Founded
2015
Focus
Radiopharmaceuticals
About
Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor
Funding History
3Total raised: $18M
Debt$5MLincoln Park CapitalMar 15, 2022
Grant$3MNational Cancer InstituteFeb 15, 2021
Series A$10MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2015
LocationAustin, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile